RA CAPITAL MANAGEMENT, L.P.

Position in MGNX — Macrogenics Inc

CIK 1346824 BOSTON, MA

Position in MGNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,387,468

-$3,461,121 QoQ

Shares Held

1,864,176

-10.5% QoQ

Ownership

2.93%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RA CAPITAL MANAGEMENT, L.P. holds $9,134,713,488 across 74 Biotechnology names. MGNX ranks #72 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	10,281,496	$2,351,686,580
2	PCVX	Vaxcyte, Inc.	11,474,599	$666,788,947
3	RYTM	Rhythm Pharmaceuticals, Inc.	6,666,837	$579,814,813
4	TYRA	Tyra Biosciences, Inc.	12,198,625	$467,207,337
5	SION	Sionna Therapeutics, Inc.	9,905,045	$397,093,254
6	EWTX	Edgewise Therapeutics, Inc.	10,428,437	$328,495,765
7	NAMS	NewAmsterdam Pharma Co N.V.	9,550,191	$305,701,613
8	NUVL	Nuvalent, Inc.	2,534,145	$259,623,155

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,387,468	1,864,176	-10.5%	Shares	Sole	2026-05-15
2024-06-30	$8,848,589	2,082,021	-48.6%	Shares	Sole	2024-08-14
2023-12-31	$38,990,600	4,053,077	-33.6%	Shares	Sole	2024-02-14
2022-03-31	$53,772,663	6,103,594	0.0%	Shares	Sole	2022-05-16
2021-12-31	$97,962,683	6,103,594	+2.7%	Shares	Sole	2022-02-14
2021-09-30	$124,458,858	5,943,594	0.0%	Shares	Sole	2021-11-15
2021-06-30	$159,644,934	5,943,594	+20.5%	Shares	Sole	2021-08-16
2021-03-31	$157,134,968	4,933,594	+12.8%	Shares	Sole	2021-05-17
2020-12-31	$100,017,460	4,375,217	0.0%	Shares	Sole	2021-02-16
2020-09-30	$110,211,716	4,375,217	-4.6%	Shares	Sole	2020-11-16
2020-06-30	$128,003,483	4,584,652	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.